<DOC>
	<DOCNO>NCT03105726</DOCNO>
	<brief_summary>End-stage heart failure ( ESHF ) represent major burden term quality life , mortality cost . The current practice France treat patient ESHF combination drug lifestyle intervention propose heart transplant ( HT ) contraindication . In Heart Diabetes Center Bad Oyenhausen ( BO ) Germany , patient present ESHF preferentially manage ventricular assist device ( VAD ) therapy . The primary purpose study compare outcomes two strategy management ESHF associate consumption resource .</brief_summary>
	<brief_title>Medical Care Versus Ventricular Assist Device Management End-stage Heart Failure ( MEVADE )</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>All patient present endstage heart failure define : A left ventricular ejection fraction ≤25 % Or oxygen consumption peak &lt; 14 mL/kg/min Or severe symptom ( NYHA class III IV ) despite optimal medical treatment Or cardiogenic shock Age 70 year Active neoplasia Suspected active systemic infection Body mass index ≥40 kg/m2 Severe chronic obstruction pulmonary disease Evidence intrinsic hepatic disease define liver enzyme value ≥ 5 time upper limit normal within 4 day randomisation , biopsy proven liver cirrhosis Significant chronic renal impairment persistent creatinine &gt; 2.5 clearance &lt; 25ml/min Pregnant lactate female Patient consideration conventional revascularization procedure , therapeutic valvular repair , leave ventricular procedure cardiomyoplasty Presence implant mechanical aortic valve convert bioprothesis time ventricular assist device implantation Evidence intrinsic hepatic disease define liver enzyme value ≥ 5 time upper limit normal , biopsy proven liver cirrhosis Occurrence stroke within 90 day history cerebrovascular disease major ( ≥ 80 % ) extracranial carotid stenosis document Doppler study Confirmation neurologist impairment cognitive function , presence Alzheimer 's disease form irreversible dementia Major peripheral vascular disease accompany pain rest leg ulceration Recent history psychiatric disease likely impair compliance Drug alcohol dependence Difficult social surroundings</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>76 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>End Stage Heart Failure</keyword>
	<keyword>New York Heart Association functional class III IV</keyword>
	<keyword>Heart transplantation</keyword>
	<keyword>Ventricular assist device</keyword>
	<keyword>Cardiogenic shock</keyword>
</DOC>